Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.41) by 9.76 percent. This is a 37.29 percent increase over losses of $(0.59) per share from the same period last year. The company reported quarterly sales of $29.47 million which beat the analyst consensus estimate of $28.47 million by 3.49 percent. This is a 3.41 percent decrease over sales of $30.51 million the same period last year.